| scholarly article | Q13442814 |
| P2093 | author name string | Kellner R | |
| Sheffield BF | |||
| Kelly AV | |||
| P433 | issue | 512 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 863-869 | |
| P577 | publication date | 1968-07-01 | |
| P1433 | published in | British Journal of Psychiatry | Q4035428 |
| P1476 | title | The assessment of changes in anxiety in a drug trial: a comparison of methods. | |
| P478 | volume | 114 |
| Q51328807 | A Controlled Trial of Benzoctamine (Ba‐30803) in Neurotic Anxiety |
| Q51316526 | A Pilot Study of the Short‐Term Antianxiety Effects of Molindone HCl |
| Q44121764 | A double-blind evaluation of diazepam and amylobarbitone in acute myocardial infarction |
| Q51293667 | A pilot study of the short-term psychotropic effects of GPA 2640. |
| Q51314066 | A self-rating scale of distress |
| Q40697948 | Assessing psychopathology in pregnancy and postpartum |
| Q51318332 | Clorazepate Dipotassium in Anxiety: A Clinical Trial with Diazepam and Placebo Controls |
| Q69742695 | Eating disorders in a general practice population. Prevalence, characteristics and follow-up at 12 to 18 months |
| Q46430831 | Hydroxyzine and chlordiazepoxide in anxious neurotic outpatients: A collaborative controlled study |
| Q24235649 | Hydroxyzine for generalised anxiety disorder |
| Q37780728 | Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder. |
| Q39913763 | Part 2. Improvement criteria in drug trials with neurotic patients |
| Q48944348 | Robert Kellner, M.D., Ph.D., 1922-1992. |
| Q39592788 | The Relief of Distress following Attendance at a Clinic |
| Q51305629 | The Short-Term Antianxiety Effects of Propranolol HCl |
| Q39690896 | The effects of chlordiazepoxide on self-rated depression, anxiety, and well-being |
Search more.